Big Rock Partners Acquisition Corp (BRPA)
Big Rock Partners Acquisition Corp
NASDAQ:BRPA (5/24/2021, 7:08:27 PM)
After market: 23.7 -0.55 (-2.27%)24.25
-3.27 (-11.88%)
Company Profile
Big Rock Partners Acquisition Corp. operates as a blank check company. The company is headquartered in Delray Beach, Florida and currently employs 2 full-time employees. The company went IPO on 2017-11-20. The firm is formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The firm is not limited to a particular industry or geographic region for purposes of consummating a business combination. The firm has not commenced any business operation and has not generated any revenue.
Company Info
Big Rock Partners Acquisition Corp
2645 N Federal Hwy Ste 230
Delray Beach FLORIDA 33483
P: 13107342300.0
CEO: Richard Ackerman
Employees: 2.0
Website: https://www.bigrockpartners.com/spac/spac_aboutus.html
BRPA News
a year ago - Kaskela Law LLCSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Shareholders to Contact the Firm/PRNewswire/ -- Kaskela Law LLC announces that it is investigating NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) ("NRx") on behalf of the company's long-term...
3 years ago - NRx PharmaceuticalsNRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq:BRPA)- Newly formed publicly traded company NRx Pharmaceuticals, Inc. (NRx) to be traded under the ticker symbol "NRXP" on the Nasdaq Global Market
3 years ago - Big Rock Partners Acquisition Corp.Big Rock Partners Acquisition Corp. Announces Effectiveness of Registration Statement; Confirms Annual Meeting Date of May 24, 2021 to Approve Proposed Merger with NeuroRxBig Rock Partners Recommends All Stockholders Vote "FOR" ALL Proposals at Annual Meeting NEW YORK, NY / ACCESSWIRE / May 21, 2021 / Big Rock Partners Acquisition Corp. ("Big Rock" or "BRPA") (Nasdaq:BRPA), a publicly traded special purpose acquisition company, today confirmed that its Annual Meeting of Stockholders (the "Annual Meeting") to consider the previously announced merger agreement with
3 years ago - NeuroRxNeuroRx and Georgian Ministry of Health Agree to Initiate Expanded Access Program of ZYESAMI (aviptadil acetate) for COVID-19 Respiratory Failure in Georgia3 years ago - NeuroRxDr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial with Remdesivir at Press Briefing by White House COVID-19 Response Team3 years ago - NeuroRxNeuroRx Responds to Issues Raised by Relief Therapeutics Regarding ZYESAMI developmentBRPA Twits
Here you can normally see the latest stock twits on BRPA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
